4
Changes in Ownership
ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000024
CEO bought 48,000 shares at an average $0.01 ($676)
From the SEC's structured data for this filing
Trades in this filing
Collier Alan Brian · CEO
Table I: Non-derivative
15 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-04-15 | Purchase : show line 1 in the form | +2,000 | $0.02 | $33 | 21,017,123 | D |
| 2019-04-16 | Purchase : show line 2 in the form | +10,000 | $0.02 | $160 | 21,027,123 | D |
| 2019-04-17 | Purchase : show line 3 in the form | +2,000 | $0.02 | $32 | 21,029,123 | D |
| 2019-04-18 | Purchase : show line 4 in the form | +12,000 | $0.01 | $167 | 21,041,123 | D |
| 2019-04-18 | Purchase : show line 5 in the form | +2,000 | $0.01 | $29 | 21,043,123 | D |
| 2019-04-18 | Purchase : show line 6 in the form | +2,000 | $0.01 | $29 | 21,045,123 | D |
| 2019-04-18 | Purchase : show line 7 in the form | +2,000 | $0.01 | $29 | 21,047,123 | D |
| 2019-04-22 | Purchase : show line 8 in the form | +2,000 | $0.01 | $26 | 21,049,123 | D |
| Open-market purchases · 48,000 sh · avg $0.01 · $676 | ||||||
Loading xslF345X03/primary_doc.xml…